CAS 200880-23-5

Pyrano[3,4-b]indole-1-acetic acid, 1,8-diethyl-1,3,4,9-tetrahydro-, ethylester

Description:

Pyrano[3,4-b]indole-1-acetic acid, 1,8-diethyl-1,3,4,9-tetrahydro-, ethylester, identified by CAS number 200880-23-5, is a chemical compound that belongs to the class of indole derivatives. This compound features a pyranoindole structure, which is characterized by a fused pyran and indole ring system. The presence of the ethyl ester functional group suggests that it may exhibit properties typical of esters, such as volatility and solubility in organic solvents. The diethyl substitution at the 1 and 8 positions of the tetrahydroindole framework indicates potential for varied reactivity and biological activity. Compounds of this nature are often investigated for their pharmacological properties, including anti-inflammatory and analgesic effects, due to the structural motifs that can interact with biological targets. Additionally, the presence of the acetic acid moiety may contribute to its solubility and reactivity. Overall, this compound's unique structure and functional groups make it a subject of interest in medicinal chemistry and drug development.

Formula: C₁₉H₂₅NO₃

Etodolac Ethyl Ester

Controlled Product

CAS: 200880-23-5

Formula: C₁₉H₂₅NO₃

Color and Shape: Neat

Molecular weight: 315.41

Ref: 86-MM0911.13

Etodolac Ethyl Ester

CAS: 200880-23-5

Formula: C₁₉H₂₅NO₃

Molecular weight: 315.41

Ref: 4Z-E-0525

Etodolac Ethyl Ester

Controlled Product

CAS: 200880-23-5

Applications Etodolac Ethyl Ester is a useful intermediate in the preparation of the new antiinflammatory drug Etodolac. Etodolac Impurity.
References Mizuguchi, E., et al.: Heterocycles, 46, 149 (1997); Woods, M., et al.: Org. Process Res. Dev., 4, 418 (2000)

Formula: C₁₉H₂₅NO₃

Color and Shape: Neat

Molecular weight: 315.41

Ref: TR-E933115

Etodolac ethyl ester

CAS: 200880-23-5

Etodolac ethyl ester is an analog of the non-steroidal anti-inflammatory drug Etodolac. It is a potent inhibitor of kinases and has been shown to induce apoptosis in cancer cells. This compound has been studied for its potential as an anticancer agent, with promising results in inhibiting tumor growth in human and Chinese hamster cells. Etodolac ethyl ester has also been found to inhibit ghrelin-induced protein kinase activity, which may have implications for the treatment of obesity and other metabolic disorders. This compound is excreted primarily in urine, making it a promising candidate for further development as a therapeutic agent.

Formula: C₁₉H₂₅NO₃

Purity: Min. 95%

Molecular weight: 315.4 g/mol

Ref: 3D-AIA88023

Etodolac Ethyl Ester

CAS: 200880-23-5

Formula: C₁₉H₂₅NO₃

Molecular weight: 315.41

Ref: ST-EA-CP-E15043